An innovative approach to enhancing the metabolism of glycolipids and reducing the need for insulin secretion in obese and type 2 diabetes patients may involve stimulating brown adipose tissue and causing the browning of white adipose tissue [28]. Here, INS is linked to type 2 diabetes mellitus.